Page last updated: 2024-08-21

tetramethylpyrazine and Osteogenic Sarcoma

tetramethylpyrazine has been researched along with Osteogenic Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, Q; Wang, Y; Zhao, W	1

Other Studies

1 other study(ies) available for tetramethylpyrazine and Osteogenic Sarcoma

Article	Year
Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo. Molecular medicine reports, 2013, Volume: 8, Issue:4 Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin D1; Down-Regulation; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Transcription Factor RelA; Tumor Burden; Xenograft Model Antitumor Assays	2013

Article

Year

Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.

Molecular medicine reports, 2013, Volume: 8, Issue:4

Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin D1; Down-Regulation; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Transcription Factor RelA; Tumor Burden; Xenograft Model Antitumor Assays

2013